Boy raises more than $13G selling baseball card collection for 2 friends with cancer Since he was 3 years old, Brady Kahle has collected baseball cards.
Indianapolis couple bumps up wedding to marry at dying mom's bedside Kristin Owens and her mother, Cheryl, had dreamed of her wedding day since Kristin was a child.
Amazon fulfills birthday wish of 8-year-old battling cancer Ordering things on Amazon offers a convenience for many families, but the service provides the Bickneses of Tuscon, much more— namely, a chance to stay home with 8-year-old Ben Bicknese, whose immune system is weakened due to cancer treatment.
FDA accepts Merck application for lung cancer combo therapy Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer, potentially giving it a major leg up in the competition for the largest cancer market.
Nutella maker fights back on palm oil after cancer risk study The $44 billion palm oil industry, under pressure in Europe after authorities listed the edible oil as a cancer risk, has found a vocal ally in the food sector: the maker of Nutella.
Women's microbiomes may give cancer warning A woman's microbiome may signal if cancer is lurking in her body, a small new study suggests.
Mammograms tied to overdiagnosis of breast cancer Widespread breast cancer screening may catch more small, slow-growing tumors that are unlikely to be fatal without curbing the diagnosis of advanced cancer cases, a Danish study suggests.
Smoking costs $1 trillion, soon to kill 8 million a year, study finds Smoking costs the global economy more than $1 trillion a year, and will kill one third more people by 2030 than it does now, according to a study by the World Health Organization and the U.S. National Cancer Institute published on Tuesday.
Does having a vasectomy increase the risk for prostate cancer? Q&A with Dr. Manny: I've been thinking of getting a vasectomy, but a friend of mine told me it could increase my risk for prostate cancer. Is this true?
FDA speeds up review of Roche's Tecentriq to treat another bladder cancer Roche said on Monday that U.S. regulators agreed to priority review of its Tecentriq immunotherapy for an additional type of bladder cancer, a boost to the Swiss drugmaker's bid to expand indications for the drug.
